CTY SCHEDULE 13D: SEC filing
Arch Venture Fund XII, L.P. and affiliated reporting persons
Filed with the SEC on · accession 0001193125-26-432028
CTY filed a SCHEDULE 13D (schedule 13d) with the SEC on Oct 26, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.1% by the first close after the filing.
Summary of the filing
Arch Venture Fund XII, L.P. and affiliated reporting persons filed a Schedule 13D joint filing agreement regarding their beneficial ownership of City Therapeutics, Inc. stock.
Key details
How CTY stock reacted
Close before
$20.77
Oct 23, 2026
First close after
+0.10%
$20.79
5 trading days
-0.29%
$20.71
Since filing
-12.13%
$18.25
✦ Ask GOAX AI about this filing — what it means for CTY, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CTY?
Click hereFrequently asked questions
What did CTY file with the SEC on Oct 26, 2026?
CTY filed a SCHEDULE 13D (SEC filing). Arch Venture Fund XII, L.P. and affiliated reporting persons filed a Schedule 13D joint filing agreement regarding their beneficial ownership of City Therapeutics, Inc. stock.
How do I read a SCHEDULE 13D?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).
How did CTY stock react to this filing?
CTY closed at $20.77 before the filing and $20.79 on Oct 26, 2026 (+0.10%). Five trading days later: $20.71 (-0.29%).
Other CTY SEC filings
Get alerts when CTY files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days